Trading FDA, Clinical Trial Binary Events at BioRunUp.com: $ISA.TO $ALKS $JAZZ $VRX $OREX
Below are summaries of the most recent articles written by Mark Messier at www.BioRunUp.com – please visit the site to read the full articles, in addition to many other free tools and strategies related to binary event investing.
This Week’s Watchlist 6/28/10
Posted: Mon, 28 Jun 2010 04:30:20 +0000
ISA.TO – Isotechnika has some explaining to do. This company has me concerned. I don’t like the semi-honest first PR from 6/23. If the FDA canceled the meeting due to problems with the application, how can we even expect them to be able to approve this on time? Be careful, this one may slip out [...]
BioRunUp.com – The Most Popular Website on Investimonials.com
Posted: Sun, 27 Jun 2010 18:20:01 +0000
For the past 2 weeks BioRunUp.com has been named the most popular site on Investimonials! I would like to say a personal “Thank You!” to my subscribers who have written reviews. I appreciate it, and please- if you have not checked out Investimonials.com or written a review for BioRunUp.com, mikehavRx.com, or BioMedReports.com please do so! As a reminder, [...]
FDA Weekly Calendar Updates 6/25/10
Posted: Fri, 25 Jun 2010 09:43:16 +0000
ALKS – PDUFA with Priority Review 10/12/10 PDLI – FDA Panel for AVASTIN for breast cancer (sBLA) 7/20/10 JAZZ – FDA Panel 8/20/10 VRX – FDA Panel 8/11/10 COV – PMA (Medical Device) Decision by FDA on expedited review for treatment of aneurysms. 11/18/10 OREX – FDA Advisory Panel 12/7/10 MELA -Response submitted to FDA on [...]
JAZZ – FDA Announces Advisory Panel Announced for 8/20
Posted: Thu, 24 Jun 2010 19:38:48 +0000
Breaking News: The FDA just released that on August 20th, an Advisory Panel will review JAZZ’s main drug candidate JZP-6 for the treatment of fibromyalgia. The news has not hit the wires yet, and JAZZ has not announced it. This bumps the run-up for JAZZ from its PDUFA date of 10/11 to the date of the [...]
www.mikehavRx.com is your prescription for stock index investing updates focused on the healthcare sector, medical innovation, and pending binary events such as FDA decisions and clinical trials. The actively managed HavRx Regulatory Catalyst Index update report is currently tracking 590 entries and 394 companies (including approximately 200 stocks trading under $5 per share and 53 private companies). Promo codes (50% discount) are available for college students, investment clubs, and subscribers to my previous FDA Calendar or similar services.
Disclosure: No positions
Tags:
Related Articles:
- Trading FDA, Clinical Trial Binary Events at BioRunUp.com: $ISTA $ARNA $VVUS $ISA.TO
- Trading FDA, Clinical Trial Binary Events: MarketGuru.com Site Closing
- Trading FDA, Clinical Trial Binary Events: $AMRN $CXSPY $AZN
- Trading FDA, Clinical Trial Binary Events: New Features at mikehavRx.com
- Trading FDA, Clinical Trial Binary Events: $ABT $CXM $AIS $ARNA $OREX $VVUS $BDSI
